San Diego Life Sciences Roundup: Health IT, Illumina, & More
(Page 2 of 2)
studies showing that proton therapy is significantly more expensive than standard radiation treatment for cancer patients.
—The student-run Rady Venture Fund at UC San Diego’s Rady School of Management joined the Tech Coast Angels and other angel investment groups in a $16 million Series B investment in Savara Pharmaceuticals of Austin, TX. Savara has been developing an inhaled antibiotic to treat methicillin-resistant Staphylococcus aureus (MRSA) infections in patients with cystic fibrosis (CF).
—The American Academy of Neurology released a mobile app during its annual meeting in San Diego this week that is intended to help users quickly assess whether someone has suffered a sports concussion. The “Concussion QuickCheck” app is available for the iOS and Android mobile platforms, and was developed in partnership with the Academy’s updated guidelines for diagnosing and evaluating sports concussions.
—Sapphire Energy, the San Diego-based industrial biotech startup, began year-round production of algae-based crude oil at its “Green Crude Farm” near Columbus, NM. Sapphire also signed its first commercial production agreement with Tesoro, the independent oil company based in San Antonio, TX.
—San Diego’s MediciNova (NASDAQ: MNOV) said data from an early stage study of ibudilast in treating opioid withdrawal has reinforced its fast track designation. The company says the early data reported in a poster session at the American Academy of Neurology annual meeting in San Diego showed a significant reduction in opioid withdrawal symptoms, no safety or tolerability issues, and no discontinuations due to treatment.